Moshe Inbar is a world-famous oncologist. Head of the Department of Oncology at Sourasky Medical Center (Ichilov). The professor conducts effective therapy for all types of cancer, he has achieved particular success in the treatment of breast cancer (BC).
He completed an internship in France, and for many years he trained in the largest clinics in the United States and in England.
For more than 30 years, Professor Inbar has been working at the Sourasky Medical Center (Ichilov).
He also runs a private practice at the Assuta Clinic.
The works of Professor Moshe Inbar are devoted to the study of topical issues in the treatment of adenocarcinoma:
The professor is also investigating the use of the synthetic drug Bevacizumab in combination with chemotherapy drugs for the treatment of HER2 (negative, locally recurrent or metastatic breast cancer).
The problem of early diagnosis of breast cancer is the focus of the study “PET in women at high risk of developing ovarian or breast cancer”, a work written in collaboration with a leading Israeli expert in the field of nuclear medicine – Professor Einat Even Sapir.